Company: CERO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001213900-25-010230
Chunk: 27

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 27
---
 in this offering. There is no established public trading market for the Offered Common Warrants or the Pre-Funded Warrants to purchase shares of our Common Stock that are being offered as part of this offering, and we do not expect a market to develop. In addition, we do not intend to apply to list the Offered Common Warrants or the Pre-Funded Warrants on any national securities exchange or other nationally recognized trading system, including the Nasdaq Global Market. Without an active market, the liquidity of the Offered Common Warrants and the Pre-Funded Warrants will be limited. The Offered Common Warrants and the Pre-Funded Warrants are speculative in nature. The Offered Common Warrants and the Pre-Funded Warrants do not confer any rights of Common Stock ownership on their holders, such as voting rights or the right to receive dividends, but rather merely represent the right to acquire shares of Common Stock at a fixed price. Specifically, commencing on the date of issuance, holders of the Offered Common Warrants may exercise their right to acquire Common Stock and pay an exercise price of $[__] per share, subject to certain adjustments, prior to five years from the date on which such Offered Common Warrants were issued, after which date any unexercised Offered Common Warrants will expire and have no further value. Holders of Pre-Funded Warrants have identical rights, except that the Pre-Funded Warrants have an exercise price of $0.001 and do not expire until exercised in full. Moreover, following this offering, the market value of the Offered Common Warrants and Pre-Funded Warrants, if any, is uncertain and there can be no assurance that the market value of the Offered Common Warrants or the Pre-Funded Warrants will equal or exceed their imputed offering price. Holders of the Offered Common Warrants and Pre-Funded Warrants offered hereby will have no rights as common stockholders with respect to the shares our common stock underlying the Offered Common Warrants and Pre-Funded Warrants until such holders exercise their Offered Common Warrants and Pre-Funded Warrants and acquire our common stock, except as otherwise provided in the Offered Common Warrants and Pre-Funded Warrants. Until holders of the Offered Common Warrants and Pre-Funded Warrants acquire shares of our Common Stock upon exercise thereof, such holders will have no rights with respect to the shares of our Common Stock underlying such warrants. Upon exercise of the Offered Common W